{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:36:38Z","timestamp":1791488198210,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38713-2","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:45:53Z","timestamp":1770662753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of artemether lumefantrine vs chloroquine for the treatment of Plasmodium Vivax infection in Pakistan"],"prefix":"10.1038","volume":"16","author":[{"given":"Sidra","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Muqtadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Ayoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed H.M.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameeullah","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ejaz A.","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"10","key":"38713_CR1","first-page":"e47127","volume":"15","author":"SS Rao","year":"2023","unstructured":"Rao, S. S., Vaidya, K. A. & Sharma, A. K. An observational study comparing the effects of chloroquine and Artemisinin-Based combination therapy on hematological recovery in patients with plasmodium Vivax malaria. Cureus 15 (10), e47127 (2023).","journal-title":"Cureus"},{"key":"38713_CR2","doi-asserted-by":"publisher","unstructured":"Ameja, C., Ogbe, P., Ibubeleye, V. & Georgewill, U. Evaluation of the Efficacy of Artemether\/Lumefantrine\/Doxycycline Combination against Plasmodium berghei in Mice. EAS J. Parasitol. Infect. Dis. 5, 36\u201342. https:\/\/doi.org\/10.36349\/easjpid.2023.v05i04.001 (2023).","DOI":"10.36349\/easjpid.2023.v05i04.001"},{"issue":"10","key":"38713_CR3","doi-asserted-by":"publisher","first-page":"e1620","DOI":"10.1002\/hsr2.1620","volume":"6","author":"S Tabassum","year":"2023","unstructured":"Tabassum, S. et al. Reflections on the surge in malaria cases after unprecedented flooding in Pakistan-A commentary. Health Sci. Rep. 6 (10), e1620 (2023).","journal-title":"Health Sci. Rep."},{"key":"38713_CR4","doi-asserted-by":"crossref","unstructured":"Jabeen, A., Ansari, J. A., Ikram, A., Khan, M. A. & Safdar, M. Impact of climate change on the epidemiology of vector-borne diseases in Pakistan. Global Biosecur. ;4(1). (2022).","DOI":"10.31646\/gbio.163"},{"key":"38713_CR5","unstructured":"WHO. World malaria report 2024 [Available from: https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024\/questions-and-answers#:~:text=This%20year\u2019s%20report%20shows%20an,increasing%20or%20decreasing%20%E2%80%93%20remain%20uncertain"},{"issue":"2","key":"38713_CR6","doi-asserted-by":"publisher","first-page":"e000198","DOI":"10.1136\/bmjgh-2016-000198","volume":"2","author":"GF Killeen","year":"2017","unstructured":"Killeen, G. F. et al. Going beyond personal protection against mosquito bites to eliminate malaria transmission: population suppression of malaria vectors that exploit both human and animal blood. BMJ Glob Health. 2 (2), e000198 (2017).","journal-title":"BMJ Glob Health"},{"issue":"20","key":"38713_CR7","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.297.20.2251","volume":"297","author":"LH Chen","year":"2007","unstructured":"Chen, L. H., Wilson, M. E. & Schlagenhauf, P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 297 (20), 2251\u20132263 (2007).","journal-title":"JAMA"},{"issue":"5","key":"38713_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2022.12366","volume":"328","author":"JP Daily","year":"2022","unstructured":"Daily, J. P., Minuti, A. & Khan, N. Diagnosis, Treatment, and prevention of malaria in the US: A review. JAMA 328 (5), 460\u2013471 (2022).","journal-title":"JAMA"},{"issue":"3","key":"38713_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jtm.12116","volume":"21","author":"S Larr\u00e9ch\u00e9","year":"2014","unstructured":"Larr\u00e9ch\u00e9, S. et al. Sensitivity of parasitological tests in imported plasmodium Vivax malaria in adults and impact of chemoprophylaxis and attack type. J. Travel Med. 21 (3), 195\u2013200 (2014).","journal-title":"J. Travel Med."},{"issue":"13","key":"38713_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMra2405313","volume":"392","author":"JP Daily","year":"2025","unstructured":"Daily, J. P., Parikh, S. & Malaria N. Engl. J. Med. ;392(13):1320\u20131333. (2025).","journal-title":"N. Engl. J. Med."},{"issue":"6 Suppl","key":"38713_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4269\/ajtmh.16-0160","volume":"95","author":"PL Olliaro","year":"2016","unstructured":"Olliaro, P. L. et al. Implications of plasmodium Vivax biology for Control, Elimination, and research. Am. J. Trop. Med. Hyg. 95 (6 Suppl), 4\u201314 (2016).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"38713_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jinf.2021.03.028","volume":"82","author":"LP Kojom Foko","year":"2021","unstructured":"Kojom Foko, L. P., Arya, A., Sharma, A. & Singh, V. Epidemiology and clinical outcomes of severe plasmodium Vivax malaria in India. J. Infect. 82 (6), 231\u2013246 (2021).","journal-title":"J. Infect."},{"issue":"1","key":"38713_CR13","first-page":"1240962","volume":"2016","author":"G Geleta","year":"2016","unstructured":"Geleta, G. & Ketema, T. Severe malaria associated with plasmodium falciparum and P. vivax among children in Pawe Hospital, Northwest Ethiopia. Malar. Res. Treat. 2016 (1), 1240962 (2016).","journal-title":"Malar. Res. Treat."},{"issue":"1","key":"38713_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/1471-2458-13-637","volume":"13","author":"T Ketema","year":"2013","unstructured":"Ketema, T. & Bacha, K. Plasmodium Vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public. Health. 13 (1), 637 (2013).","journal-title":"BMC Public. Health"},{"issue":"1","key":"38713_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12879-016-1780-z","volume":"16","author":"Y Demissie","year":"2016","unstructured":"Demissie, Y. & Ketema, T. Complicated malaria symptoms associated with plasmodium Vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia. BMC Infect. Dis. 16 (1), 436 (2016).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"38713_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jsps.2012.02.005","volume":"21","author":"M Malik","year":"2013","unstructured":"Malik, M., Hussain, A., Hassali, M. A. & Shafie, A. A. Standard treatment guidelines for malaria: challenges in its implementation in Islamabad (federal capital) and Rawalpindi (twin city), Pakistan. Saudi Pharm. J. 21 (1), 123\u2013124 (2013).","journal-title":"Saudi Pharm. J."},{"issue":"6","key":"38713_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","volume":"15","author":"The effect of dose on the antimalarial efficacy","year":"2015","unstructured":"The effect of dose on the antimalarial efficacy. Of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infect. Dis. 15 (6), 692\u2013702 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"38713_CR18","unstructured":"World Health, O. WHO guidelines for malaria, 13 July 2021. Geneva: World Health Organization; Contract No.: WHO\/UCN\/GMP\/2021.01 Rev.1. (2021) 2021."},{"issue":"10","key":"38713_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cit068","volume":"56","author":"N Senn","year":"2013","unstructured":"Senn, N. et al. Effectiveness of Artemether\/Lumefantrine for the treatment of uncomplicated plasmodium Vivax and P. falciparum malaria in young children in Papua new Guinea. Clin. Infect. Dis. 56 (10), 1413\u20131420 (2013).","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"38713_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price, R. N. et al. Global extent of chloroquine-resistant plasmodium vivax: a systematic review and meta-analysis. Lancet Infect. Dis. 14 (10), 982\u2013991 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"38713_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12936-015-0660-0","volume":"14","author":"AA Waheed","year":"2015","unstructured":"Waheed, A. A. et al. Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat. Malar. J. 14, 146 (2015).","journal-title":"Malar. J."},{"issue":"1","key":"38713_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White, N. J. Determinants of relapse periodicity in plasmodium Vivax malaria. Malar. J. 10 (1), 297 (2011).","journal-title":"Malar. J."},{"issue":"4","key":"38713_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/blood.V28.4.553.553","volume":"28","author":"E Beutler","year":"1966","unstructured":"Beutler, E. A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood 28 (4), 553\u2013562 (1966).","journal-title":"Blood"},{"key":"38713_CR24","unstructured":"News, M-P-R-D-O. Malaria - Pakistan. (2022)."},{"key":"38713_CR25","unstructured":"Disease Outbreak News. Malaria - Pakistan [press release]. (2022)."},{"key":"38713_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1475-2875-10-340","volume":"10","author":"FA Abanyie","year":"2011","unstructured":"Abanyie, F. A., Arguin, P. M. & Gutman, J. State of malaria diagnostic testing at clinical laboratories in the united States, 2010: a nationwide survey. Malar. J. 10, 340 (2011).","journal-title":"Malar. J."},{"issue":"11","key":"38713_CR27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/cid\/cis228","volume":"54","author":"ML Wilson","year":"2012","unstructured":"Wilson, M. L. Malaria rapid diagnostic tests. Clin. Infect. Dis. 54 (11), 1637\u20131641 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"38713_CR28","first-page":"53","volume":"33","author":"S Muhammad","year":"2023","unstructured":"Muhammad, S. et al. Therapeutic efficacy of chloroquine vs Artemether\/lumefantrine combination in Vivax malaria in Nowshera and surroundings. Med. Forum Monthly. 33, 53 (2023).","journal-title":"Med. Forum Monthly"},{"issue":"5","key":"38713_CR29","doi-asserted-by":"publisher","first-page":"e1002299","DOI":"10.1371\/journal.pmed.1002299","volume":"14","author":"T Abreha","year":"2017","unstructured":"Abreha, T. et al. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of plasmodium Vivax infection in ethiopia: A randomized controlled trial. PLoS Med. 14 (5), e1002299 (2017).","journal-title":"PLoS Med."},{"issue":"1","key":"38713_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1475-2875-11-280","volume":"11","author":"GK John","year":"2012","unstructured":"John, G. K. et al. Primaquine radical cure of plasmodium vivax: a critical review of the literature. Malar. J. 11 (1), 280 (2012).","journal-title":"Malar. J."},{"key":"38713_CR31","doi-asserted-by":"publisher","unstructured":"Groger, M. et al. Prospective clinical trial assessing Species-Specific efficacy of Artemether-Lumefantrine for the treatment of plasmodium malariae, plasmodium ovale, and mixed plasmodium malaria in Gabon. Antimicrob. Agents Chemother. 62(3), e01758-17. https:\/\/doi.org\/10.1128\/AAC.01758-17 (2018).","DOI":"10.1128\/AAC.01758-17"},{"issue":"1","key":"38713_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12936-022-04350-z","volume":"21","author":"A Assefa","year":"2022","unstructured":"Assefa, A. et al. Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated plasmodium Vivax infection in Ethiopia. Malar. J. 21 (1), 359 (2022).","journal-title":"Malar. J."},{"key":"38713_CR33","doi-asserted-by":"publisher","first-page":"100035","DOI":"10.1016\/j.dialog.2022.100035","volume":"1","author":"N Zaman","year":"2022","unstructured":"Zaman, N. et al. Incidence of malarial infection and response to antimalarial drugs at districts lower dir and swat of Khyber Pakhtunkhwa, Pakistan. Dialogues Health. 1, 100035 (2022).","journal-title":"Dialogues Health"},{"issue":"4","key":"38713_CR34","doi-asserted-by":"publisher","first-page":"e15373","DOI":"10.1016\/j.heliyon.2023.e15373","volume":"9","author":"MI Khan","year":"2023","unstructured":"Khan, M. I. et al. Malaria prevalence in pakistan: A systematic review and meta-analysis (2006\u20132021). Heliyon 9 (4), e15373 (2023).","journal-title":"Heliyon"},{"issue":"11","key":"38713_CR35","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.1016\/S2214-109X(16)30251-0","volume":"4","author":"A Khan","year":"2016","unstructured":"Khan, A., Godil, F. J. & Naseem, R. Chloroquine-resistant plasmodium Vivax in pakistan: an emerging threat. Lancet Glob Health. 4 (11), e790 (2016).","journal-title":"Lancet Glob Health"},{"key":"38713_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12936-015-1041-4","volume":"14","author":"S Getachew","year":"2015","unstructured":"Getachew, S. et al. Chloroquine efficacy for plasmodium Vivax malaria treatment in Southern Ethiopia. Malar. J. 14, 525 (2015).","journal-title":"Malar. J."},{"issue":"1","key":"38713_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4269\/ajtmh.2011.09-0723","volume":"84","author":"AM Yohannes","year":"2011","unstructured":"Yohannes, A. M., Teklehaimanot, A., Bergqvist, Y. & Ringwald, P. Confirmed Vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of Vivax malaria in Ethiopia. Am. J. Trop. Med. Hyg. 84 (1), 137\u2013140 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"38713_CR38","doi-asserted-by":"publisher","unstructured":"Ahmad, S. S., Rahi, M. & Sharma, A. Relapses of plasmodium Vivax malaria threaten disease elimination: time to deploy tafenoquine in India? BMJ Glob. Health. 6(2), e004558. https:\/\/doi.org\/10.1136\/bmjgh-2020-004558 (2021).","DOI":"10.1136\/bmjgh-2020-004558"},{"issue":"3","key":"38713_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0035-9203(03)00041-5","volume":"98","author":"T Leslie","year":"2004","unstructured":"Leslie, T. et al. Compliance with 14-day primaquine therapy for radical cure of Vivax malaria\u2013a randomized placebo-controlled trial comparing unsupervised with supervised treatment. Trans. R Soc. Trop. Med. Hyg. 98 (3), 168\u2013173 (2004).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"issue":"12","key":"38713_CR40","doi-asserted-by":"publisher","first-page":"e1001575","DOI":"10.1371\/journal.pmed.1001575","volume":"10","author":"NM Douglas","year":"2013","unstructured":"Douglas, N. M. et al. Major burden of severe anemia from non-falciparum malaria species in Southern papua: a hospital-based surveillance study. PLoS Med. 10 (12), e1001575 (2013). discussion e.","journal-title":"PLoS Med."},{"issue":"1","key":"38713_CR41","doi-asserted-by":"publisher","first-page":"e84555","DOI":"10.1371\/journal.pone.0084555","volume":"9","author":"K Bruxvoort","year":"2014","unstructured":"Bruxvoort, K., Goodman, C., Kachur, S. P. & Schellenberg, D. How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs. PLoS One. 9 (1), e84555 (2014).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38713-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38713-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38713-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:02:01Z","timestamp":1772575321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38713-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38713"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38713-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7978"}}